Surmodics, Inc. (SRDX) Stock Overview
Explore Surmodics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Surmodics, Inc. (SRDX)
Key Financials
Key Financials
Market Cap
614.5M
P/E Ratio
-43.41
EPS (TTM)
$-1.24
ROE
-0.13%
SRDX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Surmodics, Inc. (SRDX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $34.52.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -43.41 and a market capitalization of 614.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.